Medicenna Therapeutics Corp opened trading today at $2.44 and closed at $2.82. It traded at a low of $2.42 to a high of $2.84.

The price boosted 15.57% from the previous day's close of $2.44.

During the day across North America, the TSX Composite closed 1.42% at 22259.47, the S&P 500 closed 1.03% at 5180.74, the Dow Jones Industrial Average closed 0.46% at 38852.27 and the Nasdaq Composite closed 1.19% at 16349.25.

Medicenna Therapeutics Corp traded under MDNA on the Toronto Stock Exchange (TSX).

A total of 163,945 shares was traded during the session, with total trades of 309. On average, Medicenna Therapeutics Corp has traded 93,744 shares over the last 5-days and 134,374 year-to-date.

The TSX market on the whole today saw 2,888 price advancers against 2,298 declines and 125 unchanged.

During the prior 52 weeks, MDNA.TO has traded as high as $2.84 (May 07,2024) and low as $0.22 (November 01,2023). Moreover, in the last 52 weeks, Medicenna Therapeutics Corp's shares have risen 179.21 percent, while they have risen 571.43% year-to-date.

Following today's trading, Medicenna Therapeutics Corp has a market capitalization of $182.46 million on a float of 69,637 shares outstanding. Its annual EPS is $-0.23.

Medicenna Therapeutics Corp is a TSX Biotechnology company headquartered in Toronto, CAN.

Currently, Medicenna Therapeutics Corp's consensus rating is "Strong Buy" based on 2 analysts according to Zacks. Currently, there are 2 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..